Company / Current Liabilities
Protagonist Therapeutics, Inc. Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$45.4M
FY2025
5-year range
$21.3M / $47.4M
FY2021-FY2025
Trend
-4.1%
vs FY2024
Sector context
#149 of 213
Health Care
What the data says
At $45M, Protagonist Therapeutics, Inc.'s current liabilities ranks #65 of 213 in the Health Care sector. Current Liabilities has fluctuated over the past 10 years, ranging from $6M in FY2016 to $47M in FY2024.
Based on SEC 10-K filings.
$45M in FY2025 with a 5-year CAGR of +2.5%.
Increased from $21M to $45M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +13.4%
- 5-Year CAGR
- +2.5%
- 10-Year CAGR
- -
Sector benchmark
#65 of 213 in Health CareTop 30% of 213This company $45.4M Sector average $1.6B
▼
-97.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +2.5%, indicating consistent growth.
- In FY2025, current liabilities decreased 4.1% year-over-year.
- Ranks #149 out of 213 companies in the Health Care sector.
- Peak current liabilities was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 4.66 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $45.4M | -4.1% |
| FY2024 | $47.4M | +122.8% |
| FY2023 | $21.3M | -31.8% |
| FY2022 | $31.2M | -29.2% |
| FY2021 | $44.0M | +9.4% |
| FY2020 | $40.2M | +13.7% |
| FY2019 | $35.4M | +35.4% |
| FY2018 | $26.2M | -38.5% |
| FY2017 | $42.6M | +561.3% |
| FY2016 | $6.4M | +105.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026